Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 2, 2009, Pages

  Yang, Runkuan ^a   Miki, Keita ^a   Oksala, Niku ^b   Nakao, Atsunori ^a   Lindgren, Leena ^b   Killeen, Meaghan E ^a   Mennander, Ari ^b   Fink, Mitchell P ^a   Tenhunen, Jyrki ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Endotoxemia; Gut barrier function

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BILE FLOW; COMMON BILE DUCT; CONTROLLED STUDY; ENDOTOXEMIA; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; KUPFFER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

ANIMALS; ANTIBODIES; BILE; DEXTRANS; ENDOTOXEMIA; FLUORESCEIN-5-ISOTHIOCYANATE; HMGB1 PROTEIN; ILEUM; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PERMEABILITY; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68049094195     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00184.2009     Document Type: Article

References (32)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
2. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 112: 214-225, 1997.
3. Cakmakci M, Tirnaksiz B, Hayran M, Belek S, Gurbuz T, Sayek I. Effects of obstructive jaundice and external biliary diversion on bacterial translocation in rats. Eur J Surg 162: 567-571, 1996.
4. Clarke DL, Pillay Y, Anderson F, Thomson SR. The current standard of care in the periprocedural management of the patient with obstructive jaundice. Ann R Coll Surg Engl 88: 610-616, 2006.
5. Clements WD, McCaigue M, Erwin P, Halliday I, Rowlands BJ. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 38: 925-931, 1996.
6. Enomoto N, Ikejima K, Yamashina S, Hirose M, Shimuzu T, Takei Y, Sato, N, Thurman RG. Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res 25: 51S-54S, 2001.
7. Fink MP. Leaky gut hypothesis: a historical perspective. Crit Care Med 18: 579-80, 1990.
8. Gouma DJ, Coelho JC, Fisher JD, Schlegel JF, Li YF, Moody FG. Endotoxemia after relief of biliary obstruction by internal and external drainage in rats. Am J Surg 151: 476-479, 1986.
9. Greig JD, Krukowski ZH, Matheson NA. Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 75: 216-219, 1988.
10. Han X, Fink MP, Uchiyama T, Yang R, Delude RL. Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Gastrointest Liver Physiol 286: G126-G136, 2004.
11. Han X, Fink MP, Yang R, Delude RL. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock 21: G126-G136, 2004.
12. Jackson GD, Dai Y, Sewell WA. Bile mediates intestinal pathology in endotoxemia in rats. Infect Immun 68: 4714-4719, 2000.
13. Klinkspoor JH, Lee SP. Gallbladder mucosal function. In: Gallbladder and Biliary Tract Diseases, edited by Afdhal NH, New York: Dekker, 2000, p. 21-38.
14. Lanzini A, Jazrawi RP, Northfield TC. Simultaneous quantitative measurements of absolute gallbladder storage and emptying during fasting and eating in humans. Gastroenterology 92: 852-861, 1987.
15. Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29: S99-S106, 2001.
16. Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32: 1008-1017, 2000.
17. Muhlfeld A, Kubitz R, Dransfeld O, Haussinger D, Wettstein M. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis. Arch Biochem Biophys 413: 32-40, 2003.
18. Reynolds JV, Murchan P, Leonard N, Clarke P, Keane FB, Tanner WA. Gut barrier failure in experimental obstructive jaundice. J Surg Res 62: 11-16, 1996.
19. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leuc Biol 81: 49-58, 2007.
20. Sappington PL, Han X, Yang R, Delude RL, Fink MP. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and imunostimulated Caco-2 enterocytic monolayers. J Pharmacol Exp Ther 304: 464-476, 2003.
21. Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL, Fink MP. HMGB1 B box increases the permeability of caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123: 790-802, 2002.
22. Shaoul R, Sukhotnik I, Toubi A. Neonatal sepsis presenting as a choledochal cyst. Acta Padiatrica 97: 246-249, 2008.
23. Tamai H, Horie Y, Kato S, Yokoyama H, Ishii H. Long-term ethanol feeding enhances susceptibility of the liver to orally administered lipopolysacchrides in rats. Alcohol Clin Exp Res 26: 75S-80S, 2002.
24. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99: 12351-12356, 2002.
25. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. HMGB-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
26. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susaria SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Anderson U, Tracey KJ. Reversing established sepsis with antagonists of endogenous HMGB1. Proc Natl Acad Sci USA 101: 296-301, 2004.
27. Yang R, Gallo DJ, Baust JJ, Uchiyama T, Watkins SK, Delude RL, Fink MP. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 283: G212-G222, 2002.
28. Yang R, Han X, Delude RL, Fink MP. Ethyl pyruvate ameliorates acute alcoholic-induced liver injury and inflammation in mice. J Lab Clin Med 142: 322-331, 2003.
29. Yang R, Harada T, Li J, Uchiyama T, Han Y, Englert JA, Fink MP. Bile modulates intestinal epithelial barrier function via extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med 31: 709-717, 2005.
30. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, Galloitsch-Peerta M, Yang L, Yang H, Tracey KJ, Harbrecht BG, Billiar TR, Fink MP. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 12: 105-114, 2006.
31. Yang R, Uchiyama T, Alber SM, Han X, Watkins SK, Delude RL, Fink MP. Ringer's ethyl pyruvate solution ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis. Crit Care Med 32: 1453-1459, 2004.
32. Zhao ZF, Han DW, Liu MS, Zhang GY, Yang H, Yang LX. Expression of HMGB1 and its extracellular release of cultured primary hepatic parenchymal cells and Kupffer cells induced by LPS. Chinese J Hepatol 15: 676-680, 2007.